{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:11:16Z","timestamp":1794377476284,"version":"4.9.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-09870-7","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T17:18:18Z","timestamp":1752167898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hepatitis B virus-infected hepatocytes promote the secretion of collagen VI to the extracellular matrix"],"prefix":"10.1038","volume":"15","author":[{"given":"Alessia","family":"Virz\u00ec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakaria","family":"Boulahtouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Moehlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Meiss-Heydmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Gerges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine A.","family":"Oudot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando A.","family":"Roca Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Popp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Ramberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Mertins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Felli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Pessaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloi R.","family":"Verrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Lupberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"9870_CR1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","volume":"72","author":"AG Singal","year":"2020","unstructured":"Singal, A. G., Lampertico, P. & Nahon, P. Epidemiology and surveillance for hepatocellular carcinoma: New trends. J. Hepatol. 72, 250\u2013261. https:\/\/doi.org\/10.1016\/j.jhep.2019.08.025 (2020).","journal-title":"J. Hepatol."},{"key":"9870_CR2","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag, H. B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142, 1264\u20131273. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.061 (2012).","journal-title":"Gastroenterology"},{"key":"9870_CR3","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jhep.2019.11.003","volume":"72","author":"M Cornberg","year":"2020","unstructured":"Cornberg, M., Lok, A. S., Terrault, N. A. & Zoulim, F. Guidance for design and endpoints of clinical trials in chronic hepatitis B\u2014Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference(double dagger). J. Hepatol. 72, 539\u2013557. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.003 (2020).","journal-title":"J. Hepatol."},{"key":"9870_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-981-13-9151-4_6","volume":"1179","author":"Y Tao","year":"2020","unstructured":"Tao, Y. et al. Present and future therapies for chronic hepatitis B. Adv. Exp. Med. Biol. 1179, 137\u2013186. https:\/\/doi.org\/10.1007\/978-981-13-9151-4_6 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"9870_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1499","volume":"13","author":"J Berumen","year":"2021","unstructured":"Berumen, J., Baglieri, J., Kisseleva, T. & Mekeel, K. Liver fibrosis: Pathophysiology and clinical implications. WIREs Mech. Dis. 13, e1499. https:\/\/doi.org\/10.1002\/wsbm.1499 (2021).","journal-title":"WIREs Mech. Dis."},{"key":"9870_CR6","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1016\/j.cgh.2020.03.001","volume":"18","author":"Y Sun","year":"2020","unstructured":"Sun, Y. et al. Persistent low level of hepatitis B virus promotes fibrosis progression during therapy. Clin. Gastroenterol. Hepatol. 18, 2582\u20132591. https:\/\/doi.org\/10.1016\/j.cgh.2020.03.001 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"Suppl 1","key":"9870_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/liv.13291","volume":"37","author":"G Grossi","year":"2017","unstructured":"Grossi, G., Vigano, M., Loglio, A. & Lampertico, P. Hepatitis B virus long-term impact of antiviral therapy nucleot(s)ide analogues (NUCs). Liver Int. 37(Suppl 1), 45\u201351. https:\/\/doi.org\/10.1111\/liv.13291 (2017).","journal-title":"Liver Int."},{"key":"9870_CR8","doi-asserted-by":"publisher","unstructured":"Virzi, A., Gonzalez-Motos, V., Tripon, S., Baumert, T. F. & Lupberger, J. Profibrotic signaling and HCC risk during chronic viral hepatitis: Biomarker development. J. Clin. Med. (2021). https:\/\/doi.org\/10.3390\/jcm10050977","DOI":"10.3390\/jcm10050977"},{"key":"9870_CR9","doi-asserted-by":"publisher","unstructured":"Boulahtouf, Z., Virzi, A., Baumert, T. F., Verrier, E. R. & Lupberger, J. Signaling induced by chronic viral hepatitis: Dependence and consequences. Int. J. Mol. Sci. (2022). https:\/\/doi.org\/10.3390\/ijms23052787","DOI":"10.3390\/ijms23052787"},{"key":"9870_CR10","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/cphy.c120035","volume":"3","author":"JE Puche","year":"2013","unstructured":"Puche, J. E., Saiman, Y. & Friedman, S. L. Hepatic stellate cells and liver fibrosis. Compr. Physiol. 3, 1473\u20131492. https:\/\/doi.org\/10.1002\/cphy.c120035 (2013).","journal-title":"Compr. Physiol."},{"key":"9870_CR11","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/j.ajpath.2017.06.009","volume":"187","author":"A Kikuchi","year":"2017","unstructured":"Kikuchi, A. et al. Platelet-derived growth factor receptor alpha contributes to human hepatic stellate cell proliferation and migration. Am. J. Pathol. 187, 2273\u20132287. https:\/\/doi.org\/10.1016\/j.ajpath.2017.06.009 (2017).","journal-title":"Am. J. Pathol."},{"key":"9870_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida, T. & Friedman, S. L. Mechanisms of hepatic stellate cell activation. Nat. Rev. Gastroenterol. Hepatol. 14, 397\u2013411. https:\/\/doi.org\/10.1038\/nrgastro.2017.38 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"9870_CR13","doi-asserted-by":"publisher","first-page":"7879","DOI":"10.3892\/mmr.2017.7641","volume":"16","author":"HZ Ying","year":"2017","unstructured":"Ying, H. Z. et al. PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review). Mol. Med. Rep. 16, 7879\u20137889. https:\/\/doi.org\/10.3892\/mmr.2017.7641 (2017).","journal-title":"Mol. Med. Rep."},{"key":"9870_CR14","doi-asserted-by":"publisher","unstructured":"Gao, Q. et al. Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma. Cell 179, 561\u2013577 e522 (2019). https:\/\/doi.org\/10.1016\/j.cell.2019.08.052","DOI":"10.1016\/j.cell.2019.08.052"},{"key":"9870_CR15","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1038\/s41467-021-24010-1","volume":"12","author":"DW Ho","year":"2021","unstructured":"Ho, D. W. et al. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma. Nat. Commun. 12, 3684. https:\/\/doi.org\/10.1038\/s41467-021-24010-1 (2021).","journal-title":"Nat. Commun."},{"key":"9870_CR16","doi-asserted-by":"publisher","unstructured":"Roehlen, N. et al. Tight junction proteins and the biology of hepatobiliary disease. Int. J. Mol. Sci. (2020). https:\/\/doi.org\/10.3390\/ijms21030825","DOI":"10.3390\/ijms21030825"},{"key":"9870_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-019-0987-8","volume":"567","author":"Y Jiang","year":"2019","unstructured":"Jiang, Y. et al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature 567, 257\u2013261. https:\/\/doi.org\/10.1038\/s41586-019-0987-8 (2019).","journal-title":"Nature"},{"key":"9870_CR18","doi-asserted-by":"publisher","first-page":"30853","DOI":"10.1038\/srep30853","volume":"6","author":"H Huang","year":"2016","unstructured":"Huang, H. et al. Serum metabolomic signatures discriminate early liver inflammation and fibrosis stages in patients with chronic hepatitis B. Sci. Rep. 6, 30853. https:\/\/doi.org\/10.1038\/srep30853 (2016).","journal-title":"Sci. Rep."},{"key":"9870_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13073-016-0318-8","volume":"8","author":"JC Schoeman","year":"2016","unstructured":"Schoeman, J. C. et al. Metabolic characterization of the natural progression of chronic hepatitis B. Genome Med. 8, 64. https:\/\/doi.org\/10.1186\/s13073-016-0318-8 (2016).","journal-title":"Genome Med."},{"key":"9870_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00049","volume":"1","author":"H Yan","year":"2012","unstructured":"Yan, H. et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 1, e00049. https:\/\/doi.org\/10.7554\/eLife.00049 (2012).","journal-title":"Elife"},{"key":"9870_CR21","doi-asserted-by":"publisher","unstructured":"Arzumanian, V. A., Kiseleva, O. I. & Poverennaya, E. V. The curious case of the HepG2 cell line: 40 years of expertise. Int. J. Mol. Sci. (2021). https:\/\/doi.org\/10.3390\/ijms222313135","DOI":"10.3390\/ijms222313135"},{"key":"9870_CR22","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.celrep.2016.09.084","volume":"17","author":"ER Verrier","year":"2016","unstructured":"Verrier, E. R. et al. Solute carrier NTCP regulates innate antiviral immune responses targeting hepatitis C virus infection of hepatocytes. Cell. Rep. 17, 1357\u20131368. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.084 (2016).","journal-title":"Cell. Rep."},{"key":"9870_CR23","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","volume":"41","author":"SK Ladner","year":"1997","unstructured":"Ladner, S. K. et al. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: A novel system for screening potential inhibitors of HBV replication. Antimicrob. Agents Chemother. 41, 1715\u20131720. https:\/\/doi.org\/10.1128\/AAC.41.8.1715 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9870_CR24","doi-asserted-by":"publisher","first-page":"15655","DOI":"10.1073\/pnas.232137699","volume":"99","author":"P Gripon","year":"2002","unstructured":"Gripon, P. et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl. Acad. Sci. USA 99, 15655\u201315660. https:\/\/doi.org\/10.1073\/pnas.232137699 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9870_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jhep.2023.10.030","volume":"80","author":"MJ Heuschkel","year":"2024","unstructured":"Heuschkel, M. J. et al. JAK1 promotes HDV replication and is a potential target for antiviral therapy. J. Hepatol. 80, 220\u2013231. https:\/\/doi.org\/10.1016\/j.jhep.2023.10.030 (2024).","journal-title":"J. Hepatol."},{"key":"9870_CR26","doi-asserted-by":"publisher","unstructured":"Lucifora, J., Michelet, M., Salvetti, A. & Durantel, D. Fast differentiation of heparg cells allowing hepatitis b and delta virus infections. Cells (2020). https:\/\/doi.org\/10.3390\/cells9102288","DOI":"10.3390\/cells9102288"},{"key":"9870_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/hep.28013","volume":"63","author":"ER Verrier","year":"2016","unstructured":"Verrier, E. R. et al. A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses. Hepatology 63, 35\u201348. https:\/\/doi.org\/10.1002\/hep.28013 (2016).","journal-title":"Hepatology"},{"key":"9870_CR28","doi-asserted-by":"publisher","unstructured":"Kegel, V. et al. Protocol for isolation of primary human hepatocytes and corresponding major populations of non-parenchymal liver cells. J, Vis. Exp. e53069 (2016). https:\/\/doi.org\/10.3791\/53069","DOI":"10.3791\/53069"},{"key":"9870_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1292\/jvms.12-0396","volume":"75","author":"H Sekiguchi","year":"2013","unstructured":"Sekiguchi, H. et al. Culture on a fragmin\/protamine-coated plate suppresses the collagen type IalphaI and TGF-beta1 mRNA expression of rat hepatic stellate RI-T cells. J. Vet. Med. Sci. 75, 553\u2013559. https:\/\/doi.org\/10.1292\/jvms.12-0396 (2013).","journal-title":"J. Vet. Med. Sci."},{"key":"9870_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1083\/jcb.122.1.103","volume":"122","author":"A Desmouliere","year":"1993","unstructured":"Desmouliere, A., Geinoz, A., Gabbiani, F. & Gabbiani, G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell. Biol. 122, 103\u2013111. https:\/\/doi.org\/10.1083\/jcb.122.1.103 (1993).","journal-title":"J. Cell. Biol."},{"key":"9870_CR31","doi-asserted-by":"publisher","first-page":"20180292","DOI":"10.1098\/rstb.2018.0292","volume":"374","author":"AA Evripioti","year":"2019","unstructured":"Evripioti, A. A., Ortega-Prieto, A. M., Skelton, J. K., Bazot, Q. & Dorner, M. Phosphodiesterase-induced cAMP degradation restricts hepatitis B virus infection. Philos. Trans. R. Soc. Lond. B Biol. Sci. 374, 20180292. https:\/\/doi.org\/10.1098\/rstb.2018.0292 (2019).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"9870_CR32","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s41596-018-0006-9","volume":"13","author":"P Mertins","year":"2018","unstructured":"Mertins, P. et al. Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography-mass spectrometry. Nat. Protoc. 13, 1632\u20131661. https:\/\/doi.org\/10.1038\/s41596-018-0006-9 (2018).","journal-title":"Nat. Protoc."},{"key":"9870_CR33","doi-asserted-by":"publisher","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367\u20131372 (2008). https:\/\/doi.org\/10.1038\/nbt.1511","DOI":"10.1038\/nbt.1511"},{"key":"9870_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47. https:\/\/doi.org\/10.1093\/nar\/gkv007 (2015).","journal-title":"Nucleic Acids Res."},{"key":"9870_CR35","doi-asserted-by":"publisher","first-page":"630","DOI":"10.4049\/jimmunol.1502677","volume":"197","author":"M Yoneda","year":"2016","unstructured":"Yoneda, M. et al. Hepatitis B virus and DNA stimulation trigger a rapid innate immune response through NF-kappaB. J. Immunol. 197, 630\u2013643. https:\/\/doi.org\/10.4049\/jimmunol.1502677 (2016).","journal-title":"J. Immunol."},{"key":"9870_CR36","doi-asserted-by":"publisher","first-page":"43446","DOI":"10.1038\/srep43446","volume":"7","author":"M Wang","year":"2017","unstructured":"Wang, M. et al. Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis. Sci. Rep. 7, 43446. https:\/\/doi.org\/10.1038\/srep43446 (2017).","journal-title":"Sci. Rep."},{"key":"9870_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273. https:\/\/doi.org\/10.1038\/ng1180 (2003).","journal-title":"Nat. Genet."},{"key":"9870_CR38","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9870_CR39","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: A hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552. https:\/\/doi.org\/10.1093\/nar\/gkab1038 (2022).","journal-title":"Nucleic Acids Res."},{"key":"9870_CR40","doi-asserted-by":"publisher","unstructured":"Pant, A., Dsouza, L. & Yang, Z. Alteration in cellular signaling and metabolic reprogramming during viral infection. mBio 12, e0063521 (2021). https:\/\/doi.org\/10.1128\/mBio.00635-21","DOI":"10.1128\/mBio.00635-21"},{"key":"9870_CR41","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1038\/s41467-021-23855-w","volume":"12","author":"C Friedrich","year":"2021","unstructured":"Friedrich, C. et al. Comprehensive micro-scaled proteome and phosphoproteome characterization of archived retrospective cancer repositories. Nat. Commun. 12, 3576. https:\/\/doi.org\/10.1038\/s41467-021-23855-w (2021).","journal-title":"Nat. Commun."},{"key":"9870_CR42","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1074\/mcp.RA119.001540","volume":"18","author":"OA Arshad","year":"2019","unstructured":"Arshad, O. A. et al. An integrative analysis of tumor proteomic and phosphoproteomic profiles to examine the relationships between kinase activity and phosphorylation. Mol. Cell Proteom. 18, S26\u2013S36. https:\/\/doi.org\/10.1074\/mcp.RA119.001540 (2019).","journal-title":"Mol. Cell Proteom."},{"key":"9870_CR43","doi-asserted-by":"publisher","unstructured":"Lupberger, J. et al. Combined analysis of metabolomes, proteomes, and transcriptomes of hepatitis C virus-infected cells and liver to identify pathways associated with disease development. Gastroenterology 157, 537\u2013551 (2019). https:\/\/doi.org\/10.1053\/j.gastro.2019.04.003","DOI":"10.1053\/j.gastro.2019.04.003"},{"key":"9870_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007874","volume":"15","author":"L Qiao","year":"2019","unstructured":"Qiao, L. & Luo, G. G. Human apolipoprotein E promotes hepatitis B virus infection and production. PLoS Pathog. 15, e1007874. https:\/\/doi.org\/10.1371\/journal.ppat.1007874 (2019).","journal-title":"PLoS Pathog."},{"key":"9870_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003065","volume":"8","author":"D Ding","year":"2012","unstructured":"Ding, D. et al. Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach. PLoS Genet. 8, e1003065. https:\/\/doi.org\/10.1371\/journal.pgen.1003065 (2012).","journal-title":"PLoS Genet."},{"key":"9870_CR46","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1172\/JCI130197","volume":"130","author":"D Wu","year":"2020","unstructured":"Wu, D. et al. Plasminogen as a prognostic biomarker for HBV-related acute-on-chronic liver failure. J. Clin. Investig. 130, 2069\u20132080. https:\/\/doi.org\/10.1172\/JCI130197 (2020).","journal-title":"J. Clin. Investig."},{"key":"9870_CR47","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell. Syst. 1, 417\u2013425. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004 (2015).","journal-title":"Cell. Syst."},{"key":"9870_CR48","doi-asserted-by":"publisher","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011). https:\/\/doi.org\/10.1093\/bioinformatics\/btr260","DOI":"10.1093\/bioinformatics\/btr260"},{"key":"9870_CR49","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0092-8674(03)00926-7","volume":"115","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria. Cell 115, 629\u2013640 (2003).","journal-title":"Cell"},{"key":"9870_CR50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s43152-021-00030-3","volume":"2","author":"C Ortiz","year":"2021","unstructured":"Ortiz, C. et al. Extracellular matrix remodeling in chronic liver disease. Curr. Tissue Microenviron. Rep. 2, 41\u201352. https:\/\/doi.org\/10.1007\/s43152-021-00030-3 (2021).","journal-title":"Curr. Tissue Microenviron. Rep."},{"key":"9870_CR51","doi-asserted-by":"publisher","first-page":"15283","DOI":"10.1038\/s41598-019-51689-6","volume":"9","author":"P Erusappan","year":"2019","unstructured":"Erusappan, P., Alam, J., Lu, N., Zeltz, C. & Gullberg, D. Integrin alpha11 cytoplasmic tail is required for FAK activation to initiate 3D cell invasion and ERK-mediated cell proliferation. Sci. Rep. 9, 15283. https:\/\/doi.org\/10.1038\/s41598-019-51689-6 (2019).","journal-title":"Sci. Rep."},{"key":"9870_CR52","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-o","volume":"13","author":"PJ Scheuer","year":"1991","unstructured":"Scheuer, P. J. Classification of chronic viral hepatitis: A need for reassessment. J Hepatol 13, 372\u2013374. https:\/\/doi.org\/10.1016\/0168-8278(91)90084-o (1991).","journal-title":"J Hepatol"},{"key":"9870_CR53","doi-asserted-by":"publisher","first-page":"18417","DOI":"10.1038\/srep18417","volume":"5","author":"R Gomez-Villafuertes","year":"2015","unstructured":"Gomez-Villafuertes, R., Garcia-Huerta, P., Diaz-Hernandez, J. I. & Miras-Portugal, M. T. PI3K\/Akt signaling pathway triggers P2X7 receptor expression as a pro-survival factor of neuroblastoma cells under limiting growth conditions. Sci. Rep. 5, 18417. https:\/\/doi.org\/10.1038\/srep18417 (2015).","journal-title":"Sci. Rep."},{"key":"9870_CR54","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1172\/JCI95802","volume":"128","author":"SH Jeong","year":"2018","unstructured":"Jeong, S. H. et al. Hippo-mediated suppression of IRS2\/AKT signaling prevents hepatic steatosis and liver cancer. J. Clin. Investig. 128, 1010\u20131025. https:\/\/doi.org\/10.1172\/JCI95802 (2018).","journal-title":"J. Clin. Investig."},{"key":"9870_CR55","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/path.5536","volume":"252","author":"X Zhu","year":"2020","unstructured":"Zhu, X., Jia, X., Cheng, F., Tian, H. & Zhou, Y. c-Jun acts downstream of PI3K\/AKT signaling to mediate the effect of leptin on methionine adenosyltransferase 2B in hepatic stellate cells in vitro and in vivo. J. Pathol. 252, 423\u2013432. https:\/\/doi.org\/10.1002\/path.5536 (2020).","journal-title":"J. Pathol."},{"key":"9870_CR56","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1128\/JVI.02440-14","volume":"89","author":"S Rawat","year":"2015","unstructured":"Rawat, S. & Bouchard, M. J. The hepatitis B virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival. J. Virol. 89, 999\u20131012. https:\/\/doi.org\/10.1128\/JVI.02440-14 (2015).","journal-title":"J. Virol."},{"key":"9870_CR57","doi-asserted-by":"publisher","first-page":"10072","DOI":"10.1128\/JVI.00541-07","volume":"81","author":"H Guo","year":"2007","unstructured":"Guo, H. et al. Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway. J. Virol. 81, 10072\u201310080. https:\/\/doi.org\/10.1128\/JVI.00541-07 (2007).","journal-title":"J. Virol."},{"key":"9870_CR58","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.3892\/mmr.2018.8395","volume":"17","author":"K Xiang","year":"2018","unstructured":"Xiang, K. & Wang, B. Role of the PI3KAKTmTOR pathway in hepatitis B virus infection and replication. Mol. Med. Rep. 17, 4713\u20134719. https:\/\/doi.org\/10.3892\/mmr.2018.8395 (2018).","journal-title":"Mol. Med. Rep."},{"key":"9870_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213505","author":"M Chen","year":"2022","unstructured":"Chen, M. et al. MK-2206 alleviates renal fibrosis by suppressing the Akt\/mTOR signaling pathway in vivo and in vitro. Cells https:\/\/doi.org\/10.3390\/cells11213505 (2022).","journal-title":"Cells"},{"key":"9870_CR60","doi-asserted-by":"publisher","first-page":"9070","DOI":"10.1038\/s41598-024-58084-w","volume":"14","author":"K Stefania","year":"2024","unstructured":"Stefania, K., Ashok, K. K., Geena, P. V., Katarina, P. & Isak, D. TMAO enhances TNF-alpha mediated fibrosis and release of inflammatory mediators from renal fibroblasts. Sci. Rep. 14, 9070. https:\/\/doi.org\/10.1038\/s41598-024-58084-w (2024).","journal-title":"Sci. Rep."},{"key":"9870_CR61","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/j.tiv.2015.07.010","volume":"29","author":"VJ Barbero-Becerra","year":"2015","unstructured":"Barbero-Becerra, V. J. et al. The interplay between hepatic stellate cells and hepatocytes in an in vitro model of NASH. Toxicol. In Vitro 29, 1753\u20131758. https:\/\/doi.org\/10.1016\/j.tiv.2015.07.010 (2015).","journal-title":"Toxicol. In Vitro"},{"key":"9870_CR62","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.ajpath.2020.12.007","volume":"191","author":"H Urushima","year":"2021","unstructured":"Urushima, H. et al. Activation of hepatic stellate cells requires dissociation of e-cadherin-containing adherens junctions with hepatocytes. Am. J. Pathol. 191, 438\u2013453. https:\/\/doi.org\/10.1016\/j.ajpath.2020.12.007 (2021).","journal-title":"Am. J. Pathol."},{"key":"9870_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100887","volume":"297","author":"B Zhang","year":"2021","unstructured":"Zhang, B. et al. Trefoil factor 2 secreted from damaged hepatocytes activates hepatic stellate cells to induce fibrogenesis. J. Biol. Chem. 297, 100887. https:\/\/doi.org\/10.1016\/j.jbc.2021.100887 (2021).","journal-title":"J. Biol. Chem."},{"key":"9870_CR64","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep4.1628","volume":"5","author":"LJ Kitto","year":"2021","unstructured":"Kitto, L. J. & Henderson, N. C. Hepatic stellate cell regulation of liver regeneration and repair. Hepatol. Commun. 5, 358\u2013370. https:\/\/doi.org\/10.1002\/hep4.1628 (2021).","journal-title":"Hepatol. Commun."},{"key":"9870_CR65","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12964-023-01091-7","volume":"21","author":"H You","year":"2023","unstructured":"You, H. et al. Insights into the impact of hepatitis B virus on hepatic stellate cell activation. Cell Commun. Signal 21, 70. https:\/\/doi.org\/10.1186\/s12964-023-01091-7 (2023).","journal-title":"Cell Commun. Signal"},{"key":"9870_CR66","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.diff.2016.07.001","volume":"92","author":"D Karin","year":"2016","unstructured":"Karin, D., Koyama, Y., Brenner, D. & Kisseleva, T. The characteristics of activated portal fibroblasts\/myofibroblasts in liver fibrosis. Differentiation 92, 84\u201392. https:\/\/doi.org\/10.1016\/j.diff.2016.07.001 (2016).","journal-title":"Differentiation"},{"key":"9870_CR67","doi-asserted-by":"publisher","unstructured":"Wang, S. et al. An autocrine signaling circuit in hepatic stellate cells underlies advanced fibrosis in nonalcoholic steatohepatitis. Sci. Transl. Med. 15, eadd3949 (2023). https:\/\/doi.org\/10.1126\/scitranslmed.add3949","DOI":"10.1126\/scitranslmed.add3949"},{"key":"9870_CR68","doi-asserted-by":"publisher","unstructured":"Alexopoulou, A., Vasilieva, L. & Karayiannis, P. New Approaches to the Treatment of Chronic Hepatitis B. J Clin Med 9 (2020). https:\/\/doi.org\/10.3390\/jcm9103187","DOI":"10.3390\/jcm9103187"},{"key":"9870_CR69","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/jvh.13126","volume":"26","author":"Q Ning","year":"2019","unstructured":"Ning, Q. et al. Roadmap to functional cure of chronic hepatitis B: An expert consensus. J. Viral Hepatol. 26, 1146\u20131155. https:\/\/doi.org\/10.1111\/jvh.13126 (2019).","journal-title":"J. Viral Hepatol."},{"key":"9870_CR70","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jhep.2020.03.042","volume":"73","author":"J Lucifora","year":"2020","unstructured":"Lucifora, J. et al. Two-dimensional-cultures of primary human hepatocytes allow efficient HBV infection: Old tricks still work!. J. Hepatol. 73, 449\u2013451. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.042 (2020).","journal-title":"J. Hepatol."},{"key":"9870_CR71","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.3892\/ol.2017.5757","volume":"13","author":"F Kong","year":"2017","unstructured":"Kong, F., You, H., Tang, R. & Zheng, K. The regulation of proteins associated with the cytoskeleton by hepatitis B virus X protein during hepatocarcinogenesis. Oncol. Lett. 13, 2514\u20132520. https:\/\/doi.org\/10.3892\/ol.2017.5757 (2017).","journal-title":"Oncol. Lett."},{"key":"9870_CR72","doi-asserted-by":"publisher","unstructured":"Guan, Y. et al. Hepatitis B virus induces microtubule stabilization to promote productive infection through upregulating microtubule-associated protein 1S. J. Clin. Transl. Hepatol. 10, 467\u2013473 (2022). https:\/\/doi.org\/10.14218\/JCTH.2021.00090","DOI":"10.14218\/JCTH.2021.00090"},{"key":"9870_CR73","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41419-021-04377-1","volume":"12","author":"V De Smet","year":"2021","unstructured":"De Smet, V. et al. Initiation of hepatic stellate cell activation extends into chronic liver disease. Cell Death Dis. 12, 1110. https:\/\/doi.org\/10.1038\/s41419-021-04377-1 (2021).","journal-title":"Cell Death Dis."},{"key":"9870_CR74","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/cells9040875","volume":"9","author":"N Roehlen","year":"2020","unstructured":"Roehlen, N., Crouchet, E. & Baumert, T. F. Liver fibrosis: Mechanistic concepts and therapeutic perspectives. Cells 9, 875. https:\/\/doi.org\/10.3390\/cells9040875 (2020).","journal-title":"Cells"},{"key":"9870_CR75","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1021\/tx0500225","volume":"18","author":"D Farkas","year":"2005","unstructured":"Farkas, D., Bhat, V. B., Mandapati, S., Wishnok, J. S. & Tannenbaum, S. R. Characterization of the secreted proteome of rat hepatocytes cultured in collagen sandwiches. Chem. Res. Toxicol. 18, 1132\u20131139. https:\/\/doi.org\/10.1021\/tx0500225 (2005).","journal-title":"Chem. Res. Toxicol."},{"key":"9870_CR76","doi-asserted-by":"publisher","unstructured":"Knupp, C. et al. Reprint of \"Structural correlation between collagen VI microfibrils and collagen VI banded aggregates\" [J. Struct. Biol. 154 (2006) 312\u2013326]. J. Struct. Biol. 155, 379\u2013393 (2006). https:\/\/doi.org\/10.1016\/S1047-8477(06)00256-5","DOI":"10.1016\/S1047-8477(06)00256-5"},{"key":"9870_CR77","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.matbio.2017.12.008","volume":"71\u201372","author":"SR Lamande","year":"2018","unstructured":"Lamande, S. R. & Bateman, J. F. Collagen VI disorders: Insights on form and function in the extracellular matrix and beyond. Matrix Biol. 71\u201372, 348\u2013367. https:\/\/doi.org\/10.1016\/j.matbio.2017.12.008 (2018).","journal-title":"Matrix Biol."},{"key":"9870_CR78","doi-asserted-by":"publisher","first-page":"20753","DOI":"10.1073\/pnas.2004281117","volume":"117","author":"LM Williams","year":"2020","unstructured":"Williams, L. M. et al. Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP\/EP300. Proc. Natl. Acad. Sci. USA 117, 20753\u201320763. https:\/\/doi.org\/10.1073\/pnas.2004281117 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9870_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254557","volume":"16","author":"C Freise","year":"2021","unstructured":"Freise, C. et al. Alpha-single chains of collagen type VI inhibit the fibrogenic effects of triple helical collagen VI in hepatic stellate cells. PLoS ONE 16, e0254557. https:\/\/doi.org\/10.1371\/journal.pone.0254557 (2021).","journal-title":"PLoS ONE"},{"key":"9870_CR80","doi-asserted-by":"publisher","first-page":"H323","DOI":"10.1152\/ajpheart.00321.2005","volume":"290","author":"JE Naugle","year":"2006","unstructured":"Naugle, J. E. et al. Type VI collagen induces cardiac myofibroblast differentiation: Implications for postinfarction remodeling. Am. J. Physiol. Heart Circ. Physiol. 290, H323-330. https:\/\/doi.org\/10.1152\/ajpheart.00321.2005 (2006).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"9870_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/cells8111409","author":"S Simon Serrano","year":"2019","unstructured":"Simon Serrano, S. et al. Evaluation of NV556, a novel cyclophilin inhibitor, as a potential antifibrotic compound for liver fibrosis. Cells https:\/\/doi.org\/10.3390\/cells8111409 (2019).","journal-title":"Cells"},{"key":"9870_CR82","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1128\/JVI.02555-09","volume":"84","author":"X Tian","year":"2010","unstructured":"Tian, X. et al. Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: Possible link to pathogenesis of HBV infection. J. Virol. 84, 3373\u20133381. https:\/\/doi.org\/10.1128\/JVI.02555-09 (2010).","journal-title":"J. Virol."},{"key":"9870_CR83","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s12250-021-00450-3","volume":"36","author":"X Wang","year":"2021","unstructured":"Wang, X., Wei, Z., Jiang, Y., Meng, Z. & Lu, M. mTOR signaling: The interface linking cellular metabolism and Hepatitis B virus replication. Virol. Sin. 36, 1303\u20131314. https:\/\/doi.org\/10.1007\/s12250-021-00450-3 (2021).","journal-title":"Virol. Sin."},{"key":"9870_CR84","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1038\/s41598-023-28351-3","volume":"13","author":"H Lv","year":"2023","unstructured":"Lv, H. et al. Liver fibrosis is closely related to metabolic factors in metabolic associated fatty liver disease with hepatitis B virus infection. Sci. Rep. 13, 1388. https:\/\/doi.org\/10.1038\/s41598-023-28351-3 (2023).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09870-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09870-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09870-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:46:50Z","timestamp":1757220410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09870-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9870"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09870-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24949"}}